Found: 7
Select item for more details and to access through your institution.
Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Off-label uses of rituximab in dermatology.
- Published in:
- Dermatologic Therapy, 2007, v. 20, n. 4, p. 277, doi. 10.1111/j.1529-8019.2007.00141.x
- By:
- Publication type:
- Article
Safety and Efficacy of Tacrolimus Ointment Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids.
- Published in:
- Acta Dermato-Venereologica, 2010, v. 90, n. 1, p. 58, doi. 10.2340/00015555-0748
- By:
- Publication type:
- Article
Synopsis of Antinuclear Antibodies In Dermatology.
- Published in:
- Dermatology Nursing, 2002, v. 14, n. 3, p. 165
- By:
- Publication type:
- Article
Prevention of osteoporosis associated with chronic glucocorticoid therapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 11, p. 1300
- By:
- Publication type:
- Article
IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 12, p. 2990, doi. 10.1038/jid.2014.268
- By:
- Publication type:
- Article